Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients

Intensive Care Medicine

Volumn 42, Issue 4, 2016, Pages 551-561

  Timmermans, Kim ^a   Kox, Matthijs ^a   Vaneker, Michiel ^a,b   van den Berg, Maarten ^a   John, Aaron ^a   van Laarhoven, Arjan ^b   van der Hoeven, Hans ^a   Scheffer, Gert Jan ^a   Pickkers, Peter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; HEAT SHOCK PROTEIN 70; MITOCHONDRIAL DNA;

ADULT; AGED; BLOOD; CELL NUCLEUS; CROSS INFECTION; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; INJURY; MALE; MIDDLE AGED;

ADULT; AGED; CELL NUCLEUS; CROSS INFECTION; CYTOKINES; DNA; DNA, MITOCHONDRIAL; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; WOUNDS AND INJURIES;

EID: 84959151313     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-4205-3     Document Type: Article

References (40)

1. Dutton RP, Stansbury LG, Leone S, Kramer E, Hess JR, Scalea TM (2010) Trauma mortality in mature trauma systems: are we doing better? An analysis of trauma mortality patterns, 1997–2008. J Trauma 69:620–626
2. Peden M, McGee K, Sharma G (2002) The injury chart book: a graphical overview of the global burden of injuries. World Health Organization, Geneva
3. Adminaite D, Allsop R, Jost G (2015) Ranking EU progress on road safety: 9th road safety performance index report. European Transport Safety Council, Brussels
4. Papia G, McLellan BA, El-Helou P, Louie M, Rachlis A, Szalai JP, Simor AE (1999) Infection in hospitalized trauma patients: incidence, risk factors, and complications. J Trauma 47:923–927
5. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Brownstein BH, Mason PH, Baker HV, Finnerty CC, Jeschke MG, Lopez MC, Klein MB, Gamelli RL, Gibran NS, Arnoldo B, Xu W, Zhang Y, Calvano SE, McDonald-Smith GP, Schoenfeld DA, Storey JD, Cobb JP, Warren HS, Moldawer LL, Herndon DN, Lowry SF, Maier RV, Davis RW, Tompkins RG, Inflammation, Host Response to Injury Large-Scale Col-laborative Research Program (2011) A genomic storm in critically injured humans. J Exp Med 208:2581–2590
6. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr (1990) Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 77:204–207
7. Asehnoune K, Seguin P, Allary J, Feuillet F, Lasocki S, Cook F, Floch H, Chabanne R, Geeraerts T, Roger C, Perrigault PF, Hanouz JL, Lukasze-wicz AC, Biais M, Boucheix P, Dahyot-Fizelier C, Capdevila X, Mahe PJ, Le Maguet P, Paugam-Burtz C, Gergaud S, Plaud B, Constantin JM, Malledant Y, Flet L, Sebille V, Roquilly A, Corti-TC Study Group (2014) Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial. Lancet Respir Med 2:706–716
8. Muehlstedt SG, Lyte M, Rodriguez JL (2002) Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia. Shock 17:443–450
9. Tschoeke SK, Ertel W (2007) Immunoparalysis after multiple trauma. Injury 38:1346–1357
10. Gouel-Cheron A, Allaouchiche B, Floccard B, Rimmele T, Monneret G (2015) Early daily mHLA-DR monitoring predicts forthcoming sepsis in severe trauma patients. Intensive Care Med 41:2229–2230
11. Flach R, Majetschak M, Heukamp T, Jennissen V, Flohe S, Borgermann J, Obertacke U, Schade FU (1999) Relation of ex vivo stimulated blood cytokine synthesis to post-traumatic sepsis. Cytokine 11:173–178
12. Vester H, Dargatz P, Huber-Wagner S, Biberthaler P, van Griensven M (2015) HLA-DR expression on monocytes is decreased in polytraumatized patients. Eur J Med Res 20:84
13. West SD, Mold C (2012) Monocyte deactivation correlates with injury severity score, but not with heme oxygenase-1 levels in trauma patients. J Surg Res 172:5–10
14. Gentile LF, Moldawer LL (2013) DAMPs, PAMPs, and the origins of SIRS in bacterial sepsis. Shock 39:113–114
15. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CCM, Beck PL, Muruve DA, Kubes P (2010) Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330:362–366
16. Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, Young MF, Bruckner P, Pfeilschifter J, Schaefer RM, Grone H-J, Schaefer L (2009) Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem 284:24035–24048
17. Zhang JZ, Liu Z, Liu J, Ren JX, Sun TS (2014) Mitochondrial DNA induces inflammation and increases TLR9/NF-kappaB expression in lung tissue. Int J Mol Med 33:817–824
18. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464:104–107
19. Atamaniuk J, Ruzicka K, Stuhlmeier KM, Karimi A, Eigner M, Mueller MM (2006) Cell-free plasma DNA: a marker for apoptosis during hemodialysis. Clin Chem 52:523–526
20. Pittet JF, Lee H, Morabito D, Howard MB, Welch WJ, Mackersie RC (2002) Serum levels of Hsp 72 measured early after trauma correlate with sur-vival. J Trauma 52:611–617 (discussion 617)
21. Aneja R, Odoms K, Dunsmore K, Shanley TP, Wong HR (2006) Extracel-lular heat shock protein-70 induces endotoxin tolerance in THP-1 cells. J Immunol 177:7184–7192
22. Breitbach S, Tug S, Simon P (2012) Circulating cell-free DNA: an up-coming molecular marker in exercise physiology. Sports Med 42:565–586
23. Kox M, Timmermans K, Vaneker M, Scheffer GJ, Pickkers P (2013) Immune paralysis in trauma patients; implications for prehospital intervention. Crit Care 17:S3–S4
24. Timmermans K, Kox M, Vaneker M, Pickkers P, Scheffer GJ (2014) Immune paralysis in trauma patients; implications for prehospital intervention. Intensive Care Med 40:S246
25. Kox M, Vrouwenvelder MQ, Pompe JC, van der Hoeven JG, Pickkers P, Hoedemaekers CW (2012) The effects of brain injury on heart rate variability and the innate immune response in critically ill patients. J Neurotrauma 29:747–755
26. Pachot A, Blond JL, Mougin B, Miossec P (2004) Peptidylpropyl isomerase B (PPIB): a suitable reference gene for mRNA quantification in peripheral whole blood. J Biotechnol 114:121–124
27. Cajander S, Backman A, Tina E, Stralin K, Soderquist B, Kallman J (2013) Preliminary results in quantitation of HLA-DRA by real-time PCR: a promis-ing approach to identify immunosuppression in sepsis. Crit Care 17:R223
28. Le Tulzo Y, Pangault C, Amiot L, Guilloux V, Tribut O, Arvieux C, Camus C, Fauchet R, Thomas R, Drenou B (2004) Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. Am J Respir Crit Care Med 169:1144–1151
29. Pachot A, Monneret G, Brion A, Venet F, Bohe J, Bienvenu J, Mougin B, Lepape A (2005) Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med 33:31–38 (discussion 236–237)
30. Tabachnick BG, Fidell LS (2007) Using multivariate statistics, 5th edn, Allyn & Bacon, Needham Heights, p 635
31. Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, Payen D (2009) Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med 37:2746–2752
32. Lam NY, Rainer TH, Chiu RW, Joynt GM, Lo YM (2004) Plasma mitochon-drial DNA concentrations after trauma. Clin Chem 50:213–216
33. Chiu RW, Chan LY, Lam NY, Tsui NB, Ng EK, Rainer TH, Lo YM (2003) Quan-titative analysis of circulating mitochondrial DNA in plasma. Clin Chem 49:719–726
34. Nakos G, Malamou-Mitsi VD, Lachana A, Karassavoglou A, Kitsiouli E, Agnandi N, Lekka ME (2002) Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit Care Med 30:1488–1494
35. Howard M, O’Garra A (1992) Biological properties of interleukin 10. Immu-nol Today 13:198–200
36. Menger MD, Vollmar B (2004) Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch Surg 389:475–484
37. Wolf J, Rose-John S, Garbers C (2014) Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine 70:11–20
38. Leentjens J, Kox M, van der Hoeven JG, Netea MG, Pickkers P (2013) Immunotherapy for the adjunctive treatment of sepsis: from immuno-suppression to immunostimulation. Time for a paradigm change? Am J Respir Crit Care Med 187:1287–1293
39. Cazalis MA, Friggeri A, Cave L, Demaret J, Barbalat V, Cerrato E, Lepape A, Pachot A, Monneret G, Venet F (2013) Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock. Crit Care 17:R287
40. Fulop T, Le Page A, Fortin C, Witkowski JM, Dupuis G, Larbi A (2014) Cellular signaling in the aging immune system. Curr Opin Immunol 29:105–111